BCLS Fund IV Investments, L.P. — insider trades

Stock trades BCLS Fund IV Investments, L.P. reported on SEC Form 4 at KLRA Kailera Therapeutics, Inc..

• Apr 20, 2026: bought 1,562,500 shares of KLRA Kailera Therapeutics, Inc. ($25.0M)